-transparent.png){kind=logo}
The effect of dantrolene sodium, a skeletal muscle relaxant, on the hepatic MFO system has been investigated. The dantrolene produces a dose related inhibition of the system. Single doses of 100 mg/kg and accumulative doses up to 125 mg/kg prolong pentobarbital sleeping time and decrease the rate of aminopyrine N-demethylation without altering cytochrome P450 content. However, single doses of 400 mg/kg and accumulative doses of 500 mg/kg do cause a decrease in cytochrome P450 content as part of the dantrolene induced inhibition of the hepatic MFO system.
Related Publications
K T Francis, and
M E Hamrick
January 1971,
Xenobiotica; the fate of foreign compounds in biological systems,
K T Francis, and
M E Hamrick
November 1974,
Biochemical pharmacology,
K T Francis, and
M E Hamrick
May 1970,
Science (New York, N.Y.),
K T Francis, and
M E Hamrick
May 1981,
Biochemical pharmacology,
K T Francis, and
M E Hamrick
January 1985,
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
K T Francis, and
M E Hamrick
February 1980,
Biochimica et biophysica acta,
K T Francis, and
M E Hamrick
March 1990,
Methods and findings in experimental and clinical pharmacology,
K T Francis, and
M E Hamrick
April 1977,
Indian journal of experimental biology,
K T Francis, and
M E Hamrick
May 1984,
Bulletin of environmental contamination and toxicology,
K T Francis, and
M E Hamrick
January 1978,
Methods in enzymology,
